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Abstract
Syncope is a common and challenging presenting complaint to the Emergency Department 
(ED). Despite substantial research efforts, there is still considerable uncertainty about the 
optimal ED management of syncope. There is continued interest among clinicians and rese-
archers in improving diagnostic algorithms and optimizing resource utilization. In this paper, 
we discuss 4 strategies to improve the emergency care of syncope patients: (1) Development of 
accurate and consistent risk-stratification, (2) Increased use of syncope observation protocols, 
(3) Evaluation of a discharge with ambulatory monitoring pathway, (4) Use of shared decision-
-making for disposition decisions.
Since current risk-stratification tools have fallen short with regard to subsequent validation 
and implementation into clinical practice, we outline key factors for future risk-stratification 
research. We propose that observation units have the potential to safely decrease length-of-stay 
and hospital costs for hemodynamically stable, intermediate risk patients without adversely 
affecting clinical outcomes. For appropriate patients with a negative ED evaluation, we recom-
mend consideration of direct discharge, with ambulatory monitoring and expedited follow-up, 
as a means of decreasing costs and reducing iatrogenic harms. Finally, we advocate for the use 
of shared decision-making regarding the ultimate disposition of select, intermediate risk pa-
tients who have not had a serious condition revealed in the ED. If properly implemented, these 
four strategies could significantly improve the care of ED syncope patients by helping clinicians 
identify truly high-risk patients, decreasing unnecessary hospitalizations, and increasing pa-
tient satisfaction. (Cardiol J 2014; 21, 6: 643–650)
Key words: syncope, emergency medicine, clinical management, observation, 
risk-stratification
Introduction
Syncope is vexing presenting complaint to 
Emergency Departments (EDs) around the world. 
Visits for syncope are both common — 740,000 
annual ED visits in the United States [1], and 
costly — $2.4 billion in hospital costs yearly [2]. 
Despite many years of research on this topic [3–7], 
substantial variability in clinical management and 
uncertainty regarding best practice still persist. 
Since syncope can be precipitated by a dangerous 
condition that may remain undiagnosed during the 
ED evaluation, many patients are admitted to 
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diagnostic hospitalization is associated with minimal 
diagnostic and therapeutic yield [3, 7], and there is 
no evidence that current clinical practice improves 
quality-of-life or long-term survival [6]. According- 
ly, there is great interest within the international 
medical community to improve diagnostic algorithms 
and optimize resource utilization for syncope. 
We discuss 4 potential avenues for improving the 
ED evaluation of syncope: risk stratification tools; 
ED observation units; discharge with ambulatory 
monitoring; and shared decision-making (SDM).
Risk stratification
Figure 1 illustrates a conceptual model of the 
ED management of syncope [8]. A careful history 
and examination will help distinguish syncope from 
other symptom complexes with alternative diagno-
stic pathways, including seizure, concussion, and 
hypoglycemia. The ED workup includes selective 
testing guided by the history, exam, and electro-
cardiogram (ECG). In a minority of patients, this 
evaluation will reveal a dangerous medical condi-
tion such as symptomatic arrhythmia, pulmonary 
embolus, or severe anemia (Table 1).
In all other patients with unknown or presump-
tive diagnoses, risk stratification is the fundamental 
task for the ED provider. Patients at low risk for 
serious cardiovascular events or sudden death may 
be candidates for discharge, whereas observation 
or hospitalization may be considered for non-low 
risk patients. Persistent practice patterns suggest 
that physicians ‘over-triage’ patients with syncope 
[9]. Patients at high-risk for serious cardiovascular 
events (based on age, symptomatology, co-mor-
bidities, ECG, or serious ED diagnosis) should 
be admitted for prolonged cardiac monitoring to 
detect potentially significant arrhythmias and to 
undergo targeted investigations, (guided by the 
history, physical exam and initial testing) such as 
echocardiography, provocative cardiac testing, elec-
trophysiological evaluation to uncover any serious 
conditions amenable to intervention.
For example, few ED physicians would dis-
agree that a 90-year-old male with a history of 
ventricular tachycardia and implanted cardiac de-
vice presenting to the ED with syncope should be 
admitted. On the other end of the spectrum, most 
low-risk patients, such as young healthy adults with 
a clear benign diagnosis (e.g. situational syncope), 
should be discharged with out-patient follow-up. 
Patients who are in neither of the above catego-
ries, and therefore are intermediate risk, such as 
a 60-year-old male with one or 2 comorbidities 
and no diagnosis identified in the ED but may be 
at risk for an occult cardiac cause such as transient 
arrhythmia, create a more challenging situation for 
the ED physician. It is precisely in this cohort that 
Table 1. Dangerous causes of syncope.
Cardiac Circulatory Neurological
Bradydysrhythmias Aortic dissection Subarachnoid hemorrhage
Tachydysrhythmias Pulmonary embolism Transient ischemic attack/stroke
Structural heart disease Gastrointestinal bleeding
Myocardial infarction Ruptured abdominal aortic aneurysm
Valvular disease Ruptured ectopic pregnancy
Other significant hemorrhage
Figure 1. Conceptual model of the Emergency Department (ED) management of syncope; ECG — electrocardiogram.
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accurate risk-stratification becomes so important 
to guide further management.
To address this gap, multiple syncope risk-
-stratification tools have been developed with 
a goal of identifying patients who can safely be dis- 
charged from the ED [5, 10–14]. However, most 
of the studies have suffered from methodological 
weaknesses, small sample sizes, and variation in 
study variable definition. The initially promising 
sensitivity and specificity of these clinical decision 
instruments have not been borne out in validation 
studies [15, 16]. This is likely due, in part, to the 
inherent challenges present in studying such 
a complex clinical entity with a wide variety of 
benign and malignant etiologies. As a result, the 
dissemination and implementation of these tools 
among emergency physicians has been limited 
at best and thus they have not actually impacted 
clinical practice.
Future research aimed at risk-stratification 
must take into consideration the following key 
principles [8, 17].
(1) There must be standardization in study 
eligibility and key parameters such as predictor 
variables and adverse outcomes, as well as 
a uniform outcome time frame. Although the most 
clinically relevant time frame is debatable, a recent 
international expert panel recommended the mea-
surement of 30-day outcomes [18].
(2) Future risk-stratification studies should 
exclude patients who have a serious cause of syncope 
that is identified in the ED. Such tools are of little utili-
ty to the clinician if a dangerous diagnosis has already 
been uncovered. For example, consider a patient with 
syncope and who exhibits complete heart block on 
ECG or melena on exam with a significant decrease 
in hemoglobin. The management of this patient is 
not likely to be enhanced by the administration of 
a risk-stratification tool since the necessary interven-
tion (i.e. implanted cardiac device or endoscopy) is 
rather obvious. Inclusion of such patients in risk-
-stratification studies also biases results towards the 
identification of “obvious” problems.
(3) Clinically coherent and specific outcome 
categories should be used as opposed to general 
adverse event outcomes. Some of the reported 
syncope risk-stratification tools combine dispara-
te conditions, including arrhythmia, strokes, and 
gastrointestinal bleed, into 1 study endpoint, and 
it is unlikely that the resulting prediction tool will 
be valid for uncommon events. The use of related 
outcomes (e.g. arrhythmias and sudden death) 
would have greater face validity and likely result 
in more robust tools.
(4) Future studies should strive to enroll large 
sample sizes to mitigate the issue of rare adverse 
events and lead to more stable risk-prediction 
models. This may be more realistically achieved 
with the help of external funding.
(5) The role of novel ED tests, such as high-
-sensitivity troponins, natriuretic peptides, and 
bedside cardiac ultrasound could provide objective, 
valuable information to improve risk stratification.
(6) Future risk-stratification tools should 
generate continuous, rather than binary risk as-
sessments. In the population where the most 
clinical uncertainty exists i.e. older adults with 
a negative ED work-up, it is unlikely that a “zero-
-risk” group can be reliably identified. A continuous 
or categorical risk assessment, (e.g. low-medium-
-high) is likely to generate more nuanced, actiona-
ble and realistic information for the ED clinician.
(7) Finally, we believe that future clinical deci-
sion tools should be compared to existing physician 
performance. Such tools should outperform, on 
average, existing physician practice, which would 
justify widespread implementation.
We believe that improved risk stratification is 
a foundational step for improving ED management 
of syncope; at least 2 major multicenter studies are 
ongoing to further this objective [19, 20]. However, 
improved risk assessment must be matched to 
specific actions. For example, these tools should 
identify patients where further hospital-based 
evaluation is unlikely to be of benefit. Conversely, 
‘high’ risk patients should be admitted for further 
evaluation. The determination of such ‘discharge/ 
/admit’ thresholds is likely to be highly dependent 
on provider risk tolerance and will require further 
research and consensus.
Observation units/protocols
For non-low risk patients without an obvious 
cause for syncope, the goal of extended hospital-
-based evaluation is to uncover a dangerous cause 
that may not have been evident during the initial 
ED evaluation. This may involve hospital-based 
cardiac monitoring to capture intermittent arrhyth-
mia, echocardiogram to identify structural heart 
conditions, or serial cardiac biomarkers to ‘rule-
-out’ myocardial infarction. Hospital-based testing 
may be costly and result in low diagnostic yield 
[21–23].
Structured observation unit protocols offer 
a safe and less costly alternative to unstructured 
inpatient admission for evaluation of intermediate-
-risk patients presenting with syncope. Two rando-
www.cardiologyjournal.org 645
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mized trials of observation unit care vs. ‘routine’ 
diagnostic admission have been reported [9, 24]. 
In the Syncope Evaluation in the Emergency De-
partment Study (SEEDS), 103 patients at a single 
academic center ED were randomized and followed 
for up to 2 years [24]. The observation unit protocol 
included at least 6 h of cardiac monitoring, echocar-
diogram for patients with abnormal cardiovascular 
exam or an abnormal ECG, and tilt-table testing 
in selected patients. Electrophysiology consulta-
tion and follow-up were available to observation 
unit providers. The SEEDS study reported a 57% 
decrease in admissions in the observation group, 
and there were no differences in 2-year mortality 
or syncope recurrence between the two groups.
More recently, the ED Observation Syncope 
Protocol (EDOSP) study randomized 124 interme-
diate-risk patients presenting with syncope at 5 ED 
to structured observation vs. routine admission 
[9]. The EDOSP required at least 12 h of cardiac 
monitoring, 2 serial troponins separated by a mini-
mum of 6 h, and echocardiogram for patients with 
abnormal heart sounds. There were otherwise no 
restrictions on diagnostic testing or consultations 
that could be ordered by the treating observation 
providers. Compared to routine admission, EDOSP 
reduced length-of-stay by 18 h and hospital costs by 
$629, with no differences in 30-day safety events, 
quality-of-life scores, or patient satisfaction. The 
EDOSP study was performed at sites with a di-
versity of hospital characteristics, geography, and 
patient populations, suggesting that a structured 
observation protocol is generalizable to most set-
tings with an observation unit.
Both the SEEDS and EDOSP studies used 
semi-structured criteria and physician judgment to 
identify ‘intermediate’ risk patients eligible for ob-
servation. Physicians are likely to be highly conser-
vative; for example, almost half of screened patients 
for the EDOSP study were excluded for being ‘high 
risk.’ Improved and objective risk-stratification may 
increase the proportion of eligible patients for an 
observation protocol. In addition, changes in payer 
policies may increase the use of structured observa-
tion protocols. Since the SEEDS and EDOSP studies 
have been published, payers in the United States 
have increased scrutiny of hospitalizations for syn-
cope (e.g. Medicare Recovery Audit Contractors). 
Proprietary screening tools for inpatient eligibility 
may be less conservative than published guidelines 
and expand use of structured syncope observation 
protocols to even ‘high’ risk patients.
In summary, a structured observation protocol 
for syncope was found to be as safe as unstructured 
hospitalization while resulting in lower length-
-of-stay and costs. The presence of an existing 
observation unit, the use of a structured protocol, 
and careful screening for observation eligibility 
may safely expedite the ED evaluation of syncope. 
It should be noted that both of these trials had re-
latively small sample sizes and thus, if the health 
care economic environment were to allow it, larger, 
multicenter trials comparing observation protocols 
to admission should be conducted.
Discharge with ambulatory  
cardiac monitoring
The use of an observation protocol rather than 
unstructured hospitalization begs a more fundament - 
al question — do most patients require any hospital-
-based evaluation after a normal ED evaluation? 
The potential benefit of hospital-based evaluation 
must be weighed against the possibility of hospital-
-acquired infections, medication errors, and out-of-
-pocket costs to the patient. One important reason to 
admit patients is to identify those who might require 
cardiac device placement for potentially dangerous 
arrhythmias. We previously reviewed the medical 
charts of 2,584 older adults (≥ 60 years), who had an 
unrevealing ED evaluation for syncope [25]. Fewer 
than 7% experienced a subsequent serious medical 
event within 30 days. We found that it was often 
difficult to determine whether such events were 
related to the index syncope. The most common 
condition uncovered at 30 days was an arrhythmia 
(4%) and half of those patients received a pacema-
ker or implantable defibrillator. We conclude that 
patients with a normal ED evaluation rarely require 
a cardiac device intervention; admitting the majority 
of such patients may result in early diagnosis for 
a few but expose the rest to iatrogenic harm and costs.
One possible ED management approach mi-
mics the outpatient clinic approach: instead of 
keeping patients in the hospital for observation or 
inpatient based testing, carefully selected patients 
could be discharged directly from the ED with 
an ambulatory heart monitor. Barriers to such 
an approach may include lack of ready access to 
Holter/event monitors in the ED, lack of follow-up 
for monitor results, and patient/physician discom-
fort with ED discharge. However, a pilot study 
demonstrates that such barriers can be overcome 
[26]. There were 174 patients with suspected 
arrhythmia (symptoms of palpitations, syncope, or 
dizziness) who were discharged from a single ED 
with a single use, continuous cardiac monitoring 
device. There were no safety events and the diag-
nostic yield was 63%.
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How would patients be selected for an outpa-
tient, ambulatory approach? One factor would be 
careful risk assessment, for example, ‘high’ risk 
patients should not be sent home. For ‘interme-
diate’ risk patients, outpatient cardiac monitoring 
may be an alternative to continued hospital-based 
evaluation. Table 2 describes a previously used 
guideline for categorical risk stratification [9]. 
The next section describes a possible approach for 
selecting between these alternatives.
Shared decision-making
SDM is defined as a “process by which patients 
and providers consider outcome probabilities and 
patient preferences and reach a health care decision 
based on mutual agreement” [27]. The Institute of 
Medicine defined patient-centered care as “care 
that is respectful of and responsive to individual 
patient preferences, needs, and values” and that 
ensures “that patient values guide all clinical deci-
sions” [28]. Thus, SDM is an ideal vehicle through 
which to deliver patient centered-care. It should 
not, however, be confused with informed consent, 
as it goes much farther. Notably, SDM is featured 
in the United States Affordable Care Act (Section 
3506) and SDM research has been supported by 
the United States Patient-Centered Outcomes 
Research Institute (PCORI) [29].
SDM is appropriate in clinical scenarios in 
which there are 2 or more reasonable and appro-
priate management options. It involves several 
different components. The physician must express 
to the patient that a decision regarding his/her 
medical care needs to be made. Then, the phy-
sician should explain to the patient, in a manner 
that is clear and understandable, the nature of 
the decision, the different options that exist, and 
the potential harms and benefits of each. Finally, 
through a collaborative process, the physician and 
patient come to a mutually agreed upon course of 
action that is both medically sound and consistent 
with the patient’s values and preferences.
The practice of SDM within the context of 
emergency care has only recently gained traction. 
The literature is still in its infancy, yet we believe 
the potential is huge, specifically with regard to 
the care of ‘intermediate-risk’ ED patients with 
syncope. The concept of SDM for low-risk chest 
pain patients has been described and studied in 
a randomized fashion [30]. This single center trial, 
Chest Pain Choice, showed that use of a decision 
aid (Fig. 2) to facilitate the disposition decision 
increased patient and provider satisfaction, im-
proved post-visit patient knowledge, decreased 
hospitalization while having no effect on major 
clinical outcomes.
SDM, by actively engaging the patient and 
incorporating his/her values and preferences, has 
the potential to greatly enhance care with regards 
to both decision quality and patient satisfaction. If 
the initial ED work-up has been completed without 
revealing any serious conditions, but the patient 
is not clearly high or low risk, the ED physician 
should approach the patient and engage him/her 
in a discussion starting with what is known (e.g. 
potential causes of syncope, ED test results, 
approximate risks of adverse outcomes, risks 
of unnecessary testing and admission) and pro-
gressing towards the decision that needs to be 
made (i.e. disposition). A key component of this 
discussion would be an explicit and readily under-
standable communication of risk with the patient. 
This could be facilitated by using a personalized 
print out stating the estimated risk of 30-day 
Table 2. Risk-stratification for Emergency  
Department (ED) syncope patients.
High risk criteria
Serious condition identified in the ED
History of ventricular arrhythmia
Cardiac device with dysfunction
Exertional syncope
Presentation concerning for  
acute coronary syndrome
Severe cardiac valve disease  
(e.g., aortic stenosis < 1 cm2)
Known cardiac ejection faction < 40%
Electrocardiogram findings of QTc > 500 ms,  




No high risk features AND
No low risk features AND
Clinical judgment by emergency physician  
that patient requires further diagnostic evaluation
Low risk
Symptoms consistent with orthostatic  
or vasovagal syncope
Emergency physician judgment that no further  
diagnostic evaluation is needed
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serious clinical events based on that particular 
patient’s clinical variables using the best risk 
stratification model currently available This risk 
would be displayed as a natural frequency, percent 
risk, and graphically, using a 100-man pictogram. 
The different disposition options and potential 
downstream testing (admission to the hospital, 
admission to the observation unit, discharge with 
ambulatory monitor and scheduled follow-up, or 
discharge with primary care follow-up) for the 
patients would be listed and described in plain 
language. A fifth option, whereby the ED physi-
cian would make the disposition decision for the 
patient, would also be offered.
At that point, the patient would be invited 
to ask for additional information and then he/she 
would express his/her preferences as to what 
disposition decision he/she feels is best for them. 
Different patients, much like physicians, have dif-
ferent levels of risk tolerance as well as varying 
aversion to hospitalization and variable access to 
their outpatient physician. Many social factors 
could conceivably come into play e.g. need to feed 
pets or care for a dependent family member. If there 
truly exists more than one reasonable disposition 
option, and we argue that there often does, it is our 
responsibility to genuinely engage our patients in 
this discussion in order to deliver patient-centered 
care. Thus, we propose an additional step in the 
below clinical model (Fig. 1), “Shared decision-
-making”, which would influence step 4 “manage-
ment” via the process described above.
By bringing the patient into the decision- 
-making process, with an explicit and honest discus-
sion of risks, the moral responsibility for the outcome 
of the medical encounter could potentially be 
shared between physician and patient. All of these 
factors have the potential to mitigate the medical-
-legal risk of the physician thereby allowing for 
more emphasis on the medical needs of the patient 
as rather than engaging in ‘defensive medicine.’
We feel that the potential benefits of SDM in 
the care of ED syncope patients justify further 
research in this area. Such an intervention has the 
potential to enhance patient engagement, while 
decreasing resource utilization. Most importan-
tly, it promotes the delivery of patient-centered 
care — a standard that we, as physicians, would 
expect if we were, one day, to be syncope patients 
in an ED.
Figure 2. Chest pain choice decision aid.
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Conclusions
Despite substantial research efforts, there is 
still pervasive uncertainty about the optimal ED 
management of syncope. We propose 4 potential 
avenues to improve the emergency care of syncope 
patients:
1. Development of accurate and consistent risk-
-stratification. 
2. Increased use of syncope observation protocols.
3. Evaluation of a discharge with ambulatory 
monitoring pathway. 
4. Use of SDM for disposition decisions. 
Since current published risk stratification tools 
have not been validated for routine use, we outline 
key principles to guide future risk-stratification 
efforts. We argue that observation units have the 
potential to decrease length-of-stay and hospital 
costs while maintaining patient safety. For select 
patients with a negative evaluation, the option of 
direct discharge, with an ambulatory monitor and 
close follow-up could decrease costs and prevent 
iatrogenic harms. Finally, we propose a novel 
approach to disposition decisions, using SDM, for 
intermediate risk patients presenting with synco-
pe who have not had a serious condition revealed 
during their ED evaluation. Combined, these 
4 avenues have the potential to substantially improve 
the care of ED syncope patients.
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